DS/EN ISO 10993-16
Biological evaluation of medical devices – Part 16: Toxicokinetic study design for degradation products and leachables
inactive
Buy Now
| Organization: | DS |
| Publication Date: | 29 March 2010 |
| Status: | inactive |
| Page Count: | 26 |
| ICS Code (Biological evaluation of medical devices): | 11.100.20 |
scope:
This part of ISO 10993 gives principles on how toxicokinetic studies relevant to medical devices should be designed and performed. Annex A describes the considerations for inclusion of toxicokinetic studies in the biological evaluation of medical devices.
Document History
December 12, 2017
Biological evaluation of medical devices – Part 16: Toxicokinetic study design for degradation products and leachables
A description is not available for this item.
DS/EN ISO 10993-16
March 29, 2010
Biological evaluation of medical devices – Part 16: Toxicokinetic study design for degradation products and leachables
This part of ISO 10993 gives principles on how toxicokinetic studies relevant to medical devices should be designed and performed. Annex A describes the considerations for inclusion of toxicokinetic...
June 15, 2009
Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables
This part of IS0 10993 gives principles on how toxicokinetic studies relevant to medical devices should be designed and performed. Annex A describes the considerations for inclusion of toxicokinetic...
September 30, 1997
Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables
This part of the standard gives principles on how toxicokinetic studies relevant to medical devices should be designed and performed. Annex A describes the considerations for inclusion of...
Biological evaluation of medical devices – Part 16: Toxicokinetic study design for degradation products and leachables (ISO/FDIS 10993-16:2016)
This part of ISO 10993 gives principles on how toxicokinetic studies relevant to medical devices should be designed and performed. Annex A describes the considerations for inclusion of toxicokinetic...
Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO/FDIS 10993-16:2009)
This part of ISO 10993 gives principles on how toxicokinetic studies relevant to medical devices should be designed and performed. Annex A describes the considerations for inclusion of toxicokinetic...
Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO 10993-16:1997)
This part of IS0 10993 gives principles on how toxicokinetic studies relevant to medical devices should be designed and performed. Annex A describes the considerations for inclusion of toxicokinetic...
Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO/DIS 10993-16:2008)
This part of ISO 10993 gives principles on how toxicokinetic studies relevant to medical devices should be designed and performed. Annex A describes the considerations for inclusion of toxicokinetic...
Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO/DIS 10993-16:2016)
This part of ISO 10993 gives principles on how toxicokinetic studies relevant to medical devices should be designed and performed. Annex A describes the considerations for inclusion of toxicokinetic...
Related Products
Searching for related products...